Amarin Looks to 2013 as Potential Blockbuster Year; January 7th Presentation in Focus (AMRN)
From Trading Tips January 3, 2013 - 3:14pm
Despite rising 8% in 2012, by most accounts it was a very disappointing year for Amarin (AMRN) shareholders, according to a January 2 story in StreetInsider.com. After receiving FDA approval for Vascepa mid-year, and seeing its stock rise as much as 113%, AMRN shares hit the skids at the end of the year. Mainly, this [...]
This is the largest topic on ewallstreeter. This topic aggregates news and investment advice from over 200 different news sources. It covers all the financial markets, collectively known as Wall Street, as well as international news which affects our markets.